Literature DB >> 25117556

Profiles of Risk Among HIV-Infected Youth in Clinic Settings.

M Isabel Fernández1, Heather C Huszti, Patrick A Wilson, Shoshana Kahana, Sharon Nichols, René Gonin, Jiahong Xu, Bill G Kapogiannis.   

Abstract

Despite the rising number of new HIV infections among youth, few tailored interventions for youth living with HIV (YLH) have been developed and rigorously tested. Developing tailored interventions necessitates identifying different profiles of YLH and understanding how risk and protective factors cluster together. Obtaining this critical information requires accessing a sufficiently large sample of YLH from diverse geographic settings such as those available through the Adolescent Trials Network for HIV Interventions (ATN). We recruited a cross-sectional sample of 1,712 YLH from ATN clinics; participants completed a survey on psychosocial and health factors. Using latent class analysis on nine composite variables representing risk factors, we identified five classes distinguished by substance use, sexual behavior, and pregnancy history and differing on health outcomes. Findings suggest a need for tailored interventions addressing multiple risky behaviors of HIV-infected youth and research to clarify how intervention effectiveness may differ by risk profile.

Entities:  

Mesh:

Year:  2015        PMID: 25117556      PMCID: PMC4326610          DOI: 10.1007/s10461-014-0876-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  45 in total

1.  Emerging adulthood. A theory of development from the late teens through the twenties.

Authors:  J J Arnett
Journal:  Am Psychol       Date:  2000-05

2.  Efficacy of a preventive intervention for youths living with HIV.

Authors:  M J Rotheram-Borus; M B Lee; D A Murphy; D Futterman; N Duan; J M Birnbaum; M Lightfoot
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

3.  Health and risk behaviors over time among youth living with HIV.

Authors:  M J Rotheram-Borus; D A Murphy; M Kennedy; A Stanton; M Kuklinski
Journal:  J Adolesc       Date:  2001-12

4.  Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.

Authors:  D S Metzger; B Koblin; C Turner; H Navaline; F Valenti; S Holte; M Gross; A Sheon; H Miller; P Cooley; G R Seage
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

5.  Association between ancillary services and clinical and behavioral outcomes among HIV-infected women.

Authors:  M Magnus; N Schmidt; K Kirkhart; C Schieffelin; N Fuchs; B Brown; P J Kissinger
Journal:  AIDS Patient Care STDS       Date:  2001-03       Impact factor: 5.078

6.  Psychiatric issues in the management of patients with HIV infection.

Authors:  G J Treisman; A F Angelino; H E Hutton
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

7.  Psychiatric diagnoses in adolescents seropositive for the human immunodeficiency virus.

Authors:  M Pao; M Lyon; L J D'Angelo; W B Schuman; T Tipnis; D A Mrazek
Journal:  Arch Pediatr Adolesc Med       Date:  2000-03

8.  Impact of psychiatric conditions on health-related quality of life in persons with HIV infection.

Authors:  C D Sherbourne; R D Hays; J A Fleishman; B Vitiello; K M Magruder; E G Bing; D McCaffrey; A Burnam; D Longshore; F Eggan; S A Bozzette; M F Shapiro
Journal:  Am J Psychiatry       Date:  2000-02       Impact factor: 18.112

9.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).

Authors:  M A Chesney; J R Ickovics; D B Chambers; A L Gifford; J Neidig; B Zwickl; A W Wu
Journal:  AIDS Care       Date:  2000-06

10.  No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress.

Authors:  D A Murphy; S J Durako; A B Moscicki; S H Vermund; Y Ma; D F Schwarz; L R Muenz
Journal:  J Adolesc Health       Date:  2001-09       Impact factor: 5.012

View more
  7 in total

1.  Predictors of Self-Reported Adherence to Antiretroviral Medication in a Multisite Study of Ethnic and Racial Minority HIV-Positive Youth.

Authors:  Karen Kolmodin MacDonell; Angela J Jacques-Tiura; Sylvie Naar; Maria Isabella Fernandez
Journal:  J Pediatr Psychol       Date:  2015-10-24

Review 2.  Stopping the rise of HIV among adolescents globally.

Authors:  Mary Jane Rotheram-Borus; Emily Davis; Roxana Rezai
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

3.  Behavioral Health and Adult Milestones in Young Adults With Perinatal HIV Infection or Exposure.

Authors:  Elaine J Abrams; Claude A Mellins; Amelia Bucek; Curtis Dolezal; Jeannette Raymond; Andrew Wiznia; Andrea Jurgrau; Mahrukh Bamji; Cheng-Shiun Leu; Yiu Kee Warren Ng
Journal:  Pediatrics       Date:  2018-08-10       Impact factor: 7.124

4.  The Usefulness of the CRAFFT in Screening for Problematic Drug and Alcohol Use Among Youth Living with HIV.

Authors:  Kristi E Gamarel; Kimberly M Nelson; Larry Brown; M Isabel Fernandez; Sharon Nichols
Journal:  AIDS Behav       Date:  2017-07

5.  Receipt of clinical and prevention services, clinical outcomes, and sexual risk behaviors among HIV-infected young adults in care in the United States.

Authors:  Linda Beer; Christine L Mattson; R Luke Shouse; Joseph Prejean
Journal:  AIDS Care       Date:  2016-03-24

6.  Prevalence and correlates of substance use among youth living with HIV in clinical settings.

Authors:  Kristi E Gamarel; Larry Brown; Christopher W Kahler; M Isabel Fernandez; Douglas Bruce; Sharon Nichols
Journal:  Drug Alcohol Depend       Date:  2016-10-11       Impact factor: 4.492

7.  Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth.

Authors:  Jessica A Kahn; Bret J Rudy; Jiahong Xu; Bill Kapogiannis; Elizabeth Secord; Maura Gillison
Journal:  J Med Virol       Date:  2016-05-09       Impact factor: 2.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.